Effect of 1, 25-dihyroxyvitamin D3 on Senile Osteoporosis

[1]  T. Fujita,et al.  Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism. , 1982, The Journal of clinical endocrinology and metabolism.

[2]  B. Roos,et al.  DEFICIENT CALCITONIN RESPONSE TO CALCIUM STIMULATION IN POSTMENOPAUSAL OSTEOPOROSIS? , 1982, The Lancet.

[3]  J. Adams,et al.  Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. , 1981, The New England journal of medicine.

[4]  M. Whitehead,et al.  CALCITONIN AND THE CALCIUM-REGULATING HORMONES IN POSTMENOPAUSAL WOMEN: EFFECT OF OESTROGENS , 1981, The Lancet.

[5]  H. DeLuca,et al.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. , 1979, The Journal of clinical investigation.

[6]  R. Horst,et al.  25-OHD3-26,23-lactone: a metabolite of vitamin D3 that is 5 times more potent than 25-OHD3 in the rat plasma competitive protein binding radioassay. , 1979, Biochemical and biophysical research communications.

[7]  M. Harasawa,et al.  Endocrine factors in senile osteoporosis. , 1979, Endocrinologia japonica.

[8]  B. Lämmle,et al.  1,25 (OH)2 Vitamin D3 in Osteoporosis - A Pilot Study* ** , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  P. Adams,et al.  Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in osteoporosis. , 1977, Calcified tissue research.

[10]  M. Yoshikawa,et al.  Effects of age and diseases on human serum 25-hydroxycholecalciferol determined by competitive protein-binding assay. , 1976, Endocrinologia japonica.

[11]  B. J. Davidson,et al.  Total and free estrogens and androgens in postmenopausal women with hip fractures. , 1982, The Journal of clinical endocrinology and metabolism.

[12]  P. Kelly,et al.  Parathyroid function in primary osteoporosis. , 1973, The Journal of clinical investigation.